ABSTRACT
In response to the Covid-19 pandemic, Egypt adopted a unique care model based on quarantine hospitals for Covid-19 patients, with dedicated medical teams residing in the hospital days and nights during working shifts. However, the impact of this approach on the infection risk for healthcare workers (HCWs) is uncertain.
Based on data collected within two quarantine hospitals located in Cairo, Egypt, we compute the incidence of SARS-CoV-2 infection in health-care workers (HCWs) using a model-based approach that accounts for variability in false-negative rates of RT-PCR tests. We estimate the probability for an HCW to be infected at the end of a working shift at 12.8% (95% CrI: 7.6%-19.5%) for a 2- week shift at Hospital 1, whereas a higher probability of 48.2% (95%CrI: 23.8%-74.5%) was found for a 7-day shift at Hospital 2.
The large variation in the infection risk we describe between the two hospitals we studied suggests that HCWs from quarantine hospitals may face a high risk of infection, but that, with sufficient anticipation and infection control measures, this risk can be brought down to levels similar to those observed in standard healthcare settings.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by INSERM-ANRS (France Recherche Nord and Sud Sida-HIV Hepatites, grant number ANRS-COV-19.).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the Research Ethics Committee (REC) of the Central Directorate of Research and Health Development and Reviews at the Egyptian Ministry of Health and Population (Serial: 25-2020/16), and by REC for human subject research at the Faculty of Medicine, Helwan University (Serial: 50-2020).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Please contact the corresponding author for access to the data